Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833482 · ClinicalTrials.gov registry record · Phase 1
Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 185
- Enrollment target
NCT00833482: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT00833482 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 185 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (208% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00833482, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 185 participants
- Enrollment target
Study Summary
This study assesses the effects of voriconazole, 200 mg, administered twice daily (BID), on the steady-state pharmacokinetics of atazanavir administered as atazanavir/ritonavir, 300/100 mg once daily (QD), in healthy participants with functional CYP2C19 alleles. The study also reviews the effects of atazanavir/ritonavir, 300/100 mg QD, on the pharmacokinetics of voriconazole, 200 mg, BID in healthy participants with functional CYP2C19 alleles.
Primary Outcome
EM participants are those with functional CYP2C19 alleles.
Interventions
- DRUG Ritonavir
- DRUG Atazanavir
- DRUG Voriconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-02 |
| Phase | Phase 1 |
What the finished NCT00833482 record still lists
NCT00833482 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (208% higher).
The record links to 0 conditions, and to 3 interventions - of which Ritonavir is the first listed.
NCT00833482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00833482 about?
NCT00833482 is a clinical study titled "Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants". This study assesses the effects of voriconazole, 200 mg, administered twice daily (BID), on the steady-state pharmacokinetics of atazanavir administered as atazanavir/ritonavir, 300/100 mg once daily (QD), in healthy participants with functional CYP2C19 alleles. The study also reviews the effects of...
What is the current status of trial NCT00833482?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 185 participants. The study started on 2009-09. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00833482?
The interventions under investigation include: Ritonavir (DRUG), Atazanavir (DRUG), Voriconazole (DRUG).
Who is sponsoring clinical trial NCT00833482?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00833482's enrollment target sits among peer trials
185 294th of 2000 higher than 1,707 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia